[1]

[2]

SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.

[3]

LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.

[4]

YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.

[5]

XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.

[6]

CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.

[7]

. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.

[8]

. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.

[9]

[10]

YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.

[11]

DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.

[12]

GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.

[13]

. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.

[14]

. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.

[15]

. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.

稀释比例	结果（pg/mL）	期望值（pg/mL）	回收率（%）	偏移（%）
原倍	无效	1 346.0
4∶1	1 077	1 077.0	100	0
2∶3	1 239	538.4	23	-77
1∶4	5 850	269.2	2 173	2 073

稀释比例	结果（pg/mL）	期望值（pg/mL）	回收率（%）	偏移（%）
原倍	无效	1 346.0
4∶1	1 077	1 077.0	100	0
2∶3	1 239	538.4	23	-77
1∶4	5 850	269.2	2 173	2 073

RichHTML

PDF (PC)

[1]	NT-proBNP临床应用中国专家共识小组. NT-proBNP临床应用中国专家共识[J]. 中国心血管病研究,2011,9(6):401-408.
[2]	闫睿. 2013中国心力衰竭指南更新要点[J]. 中国循证心血管医学杂志,2013,5(2):160.
[3]	尚红,王毓三,申子瑜,等. 全国临床检验操作规程[M]. 4版. 北京:人民卫生出版社,2015:400-401.
[4]	袁克宇,伏春琴,蔡红军. ELISA法检测抗-HIV 假阳性原因探究[J]. 中国输血杂志,2002,15(4):246-247.
[5]	陈会强. 人抗鼠抗体(HAMAs)干扰导致BNP假阳性一例[D]. 杭州:浙江大学,2010.